Xcorporeal Company Insiders
| XCRP Stock | USD 0.0001 0.00 0.00% |
Xcorporeal employs about 24 people. The company is managed by 3 executives with a total tenure of roughly 18 years, averaging almost 6.0 years of service per executive, having 8.0 employees per reported executive. Discussion of Xcorporeal's management performance can provide insight into the enterprise performance.
| Terren Peizer Director Executive Director |
Xcorporeal | Build AI portfolio with Xcorporeal Stock |
Xcorporeal Management Team Effectiveness
The company has return on total asset (ROA) of (1.4921) % which means that it has lost $1.4921 on every $100 spent on assets. This is way below average. Xcorporeal's management efficiency ratios could be used to measure how well Xcorporeal manages its routine affairs as well as how well it operates its assets and liabilities.Xcorporeal Workforce Comparison
Xcorporeal is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 525. Xcorporeal holds roughly 24.0 in number of employees claiming about 5% of equities under Health Care industry.
Xcorporeal Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Xcorporeal Price Series Summation is a cross summation of Xcorporeal price series and its benchmark/peer.
Xcorporeal Notable Stakeholders
A Xcorporeal stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Xcorporeal often face trade-offs trying to please all of them. Xcorporeal's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Xcorporeal's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Terren Peizer | Executive Director | Profile | |
| Len Braganza | Vice Marketing | Profile | |
| Victor MD | Chief Officer | Profile |
About Xcorporeal Management Performance
The success or failure of an entity such as Xcorporeal often depends on how effective the management is. Xcorporeal management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Xcorporeal management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Xcorporeal management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California. Xcorporeal is traded on OTC Exchange in the United States.
Xcorporeal Workforce Analysis
Traditionally, organizations such as Xcorporeal use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Xcorporeal within its industry.Xcorporeal Manpower Efficiency
Return on Xcorporeal Manpower
| Revenue Per Employee | 4.96 | |
| Revenue Per Executive | 39.67 | |
| Net Loss Per Employee | 176 | |
| Net Loss Per Executive | 1.4K |
Additional Tools for Xcorporeal Stock Analysis
When running Xcorporeal's price analysis, check to measure Xcorporeal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xcorporeal is operating at the current time. Most of Xcorporeal's value examination focuses on studying past and present price action to predict the probability of Xcorporeal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xcorporeal's price. Additionally, you may evaluate how the addition of Xcorporeal to your portfolios can decrease your overall portfolio volatility.